This Indemnification Agreement is made and entered into this 25th day of November, 2002, between Nabi
Biopharmaceuticals (the "Company") and Daniel Greenleaf (the "Indemnitee"), and is effective retroactively to the
date of hire of the Indemnitee by Company.
The board of directors of the Company has determined that highly competent persons will be difficult to retain
unless they are adequately protected against liabilities incurred in performance of their services on behalf of the
Company, and the Company's By-laws authorize the Company to enter into and perform Indemnification
Agreements for this purpose.
Therefore, the board of directors has determined that it is in the best interests of the Company to attract and
retain persons such as the Indemnitee by providing adequate protection against such liabilities by means of
Indemnification Agreements with persons such as the Indemnitee.
NOW, THEREFORE, in consideration of the promises and covenants contained herein and as an inducement to
the Indemnitee to continue as an employee of the Company, the Company and the Indemnitee, intending to be
legally bound, do hereby agree as follows:
1. The Indemnitee agrees to serve as an employee of the Company until the Indemnitee's resignation by written
notice to the Company or the Indemnitee's removal, whichever occurs earliest.
2. The Company agrees to indemnify and hold harmless the Indemnitee, with respect to any action taken or
omitted by the Indemnitee while serving as an employee of the Company, to the fullest extent permissible under
applicable law, as such law may be amended or supplemented from time to time. The Indemnitee's
indemnification rights shall include but not be limited to the rights contained in the following paragraphs, except to
the extent expressly prohibited by applicable law.
3. The Company shall indemnify and hold harmless the Indemnitee from and against expenses (including